APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Preventive

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Asthma Preventive Market Outlook and Growth Opportunities 2026

20 December 2025197 pages

Choose your research edition.

Industry ResearchAsthma Preventive Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Preventive Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Asthma Preventive Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Preventive Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Preventive Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Asthma Preventive market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Preventive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Asthma Preventive market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Asthma Preventive market include Novartis, Merck, Roche, Pfizer, GSK, Amgen, Astrazeneca, Sumitomo Dainippon Pharma and Chiesi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Preventive market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Preventive and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Preventive sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Preventive market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Preventive Segment by Company

Novartis

Merck

Roche

Pfizer

GSK

Amgen

Astrazeneca

Sumitomo Dainippon Pharma

Chiesi

Boehringer Ingelheim

Biotest AG

Abbot

Asthma Preventive Segment by Type

Sodium Cromolyn

Prednisolone

Asthma Preventive Segment by Application

Children

Adult

Asthma Preventive Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Asthma Preventive status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Asthma Preventive market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Asthma Preventive significant trends, drivers, influence factors in global and regions.

6. To analyze Asthma Preventive competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Preventive market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Preventive and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Preventive.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Preventive market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Asthma Preventive industry.

Chapter 3: Detailed analysis of Asthma Preventive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Asthma Preventive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Asthma Preventive in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Asthma Preventive Industry Trends Table 2. Asthma Preventive Industry Drivers Table 3. Asthma Preventive Industry Opportunities and Challenges Table 4. Asthma Preventive Industry Restraints Table 5. Global Asthma Preventive Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Asthma Preventive Revenue Share by Company (2021-2026) Table 7. Global Asthma Preventive Sales Volume by Company (k units) & (2021-2026) Table 8. Global Asthma Preventive Sales Volume Share by Company (2021-2026) Table 9. Global Asthma Preventive Average Price (US$/unit) of Company (2021-2026) Table 10. Global Asthma Preventive Company Ranking, (2024-2026) & (USD Million) Table 11. Global Asthma Preventive Key Company Manufacturing Base & Headquarters Table 12. Global Asthma Preventive Company, Product Type & Application Table 13. Global Asthma Preventive Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Preventive by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sodium Cromolyn Table 18. Significant Companies of Prednisolone Table 19. Global Asthma Preventive Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Asthma Preventive Sales Volume by Type (2021-2026) & (k units) Table 21. Global Asthma Preventive Sales Volume by Type (2027-2032) & (k units) Table 22. Global Asthma Preventive Sales Volume Share by Type (2021-2026) Table 23. Global Asthma Preventive Sales Volume Share by Type (2027-2032) Table 24. Global Asthma Preventive Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Asthma Preventive Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Asthma Preventive Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Asthma Preventive Sales Value Share by Type (2021-2026) Table 28. Global Asthma Preventive Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Children Table 30. Significant Companies of Adult Table 31. Global Asthma Preventive Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Asthma Preventive Sales Volume by Application (2021-2026) & (k units) Table 33. Global Asthma Preventive Sales Volume by Application (2027-2032) & (k units) Table 34. Global Asthma Preventive Sales Volume Share by Application (2021-2026) Table 35. Global Asthma Preventive Sales Volume Share by Application (2027-2032) Table 36. Global Asthma Preventive Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Asthma Preventive Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Asthma Preventive Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Asthma Preventive Sales Value Share by Application (2021-2026) Table 40. Global Asthma Preventive Sales Value Share by Application (2027-2032) Table 41. Global Asthma Preventive Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Asthma Preventive Sales by Region (2021-2026) & (k units) Table 43. Global Asthma Preventive Sales Market Share by Region (2021-2026) Table 44. Global Asthma Preventive Sales by Region (2027-2032) & (k units) Table 45. Global Asthma Preventive Sales Market Share by Region (2027-2032) Table 46. Global Asthma Preventive Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Asthma Preventive Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Asthma Preventive Sales Value Share by Region (2021-2026) Table 49. Global Asthma Preventive Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Asthma Preventive Sales Value Share by Region (2027-2032) Table 51. Global Asthma Preventive Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Asthma Preventive Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Asthma Preventive Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global Asthma Preventive Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Asthma Preventive Sales by Country (2021-2026) & (k units) Table 56. Global Asthma Preventive Sales Market Share by Country (2021-2026) Table 57. Global Asthma Preventive Sales by Country (2027-2032) & (k units) Table 58. Global Asthma Preventive Sales Market Share by Country (2027-2032) Table 59. Global Asthma Preventive Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Asthma Preventive Sales Value Market Share by Country (2021-2026) Table 61. Global Asthma Preventive Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Asthma Preventive Sales Value Market Share by Country (2027-2032) Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Novartis Asthma Preventive Product Portfolio Table 67. Novartis Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck Asthma Preventive Product Portfolio Table 72. Merck Recent Development Table 73. Roche Company Information Table 74. Roche Business Overview Table 75. Roche Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Roche Asthma Preventive Product Portfolio Table 77. Roche Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Pfizer Asthma Preventive Product Portfolio Table 82. Pfizer Recent Development Table 83. GSK Company Information Table 84. GSK Business Overview Table 85. GSK Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. GSK Asthma Preventive Product Portfolio Table 87. GSK Recent Development Table 88. Amgen Company Information Table 89. Amgen Business Overview Table 90. Amgen Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Amgen Asthma Preventive Product Portfolio Table 92. Amgen Recent Development Table 93. Astrazeneca Company Information Table 94. Astrazeneca Business Overview Table 95. Astrazeneca Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Astrazeneca Asthma Preventive Product Portfolio Table 97. Astrazeneca Recent Development Table 98. Sumitomo Dainippon Pharma Company Information Table 99. Sumitomo Dainippon Pharma Business Overview Table 100. Sumitomo Dainippon Pharma Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio Table 102. Sumitomo Dainippon Pharma Recent Development Table 103. Chiesi Company Information Table 104. Chiesi Business Overview Table 105. Chiesi Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Chiesi Asthma Preventive Product Portfolio Table 107. Chiesi Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Asthma Preventive Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Biotest AG Company Information Table 114. Biotest AG Business Overview Table 115. Biotest AG Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Biotest AG Asthma Preventive Product Portfolio Table 117. Biotest AG Recent Development Table 118. Abbot Company Information Table 119. Abbot Business Overview Table 120. Abbot Asthma Preventive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Abbot Asthma Preventive Product Portfolio Table 122. Abbot Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Asthma Preventive Distributors List Table 126. Asthma Preventive Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Asthma Preventive Product Image Figure 2. Global Asthma Preventive Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Preventive Sales Value (2021-2032) & (US$ Million) Figure 4. Global Asthma Preventive Sales (2021-2032) & (k units) Figure 5. Global Asthma Preventive Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Asthma Preventive Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sodium Cromolyn Image Figure 10. Prednisolone Image Figure 11. Global Asthma Preventive Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Asthma Preventive Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Asthma Preventive Sales Volume Share by Type (2021-2032) Figure 14. Global Asthma Preventive Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Asthma Preventive Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Asthma Preventive Sales Value Share by Type (2021-2032) Figure 17. Children Image Figure 18. Adult Image Figure 19. Global Asthma Preventive Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Asthma Preventive Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Asthma Preventive Sales Volume Share by Application (2021-2032) Figure 22. Global Asthma Preventive Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Asthma Preventive Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Asthma Preventive Sales Value Share by Application (2021-2032) Figure 25. Global Asthma Preventive Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global Asthma Preventive Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Asthma Preventive Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Asthma Preventive Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Asthma Preventive Sales Value (2021-2032) & (US$ Million) Figure 30. North America Asthma Preventive Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Asthma Preventive Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Asthma Preventive Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Asthma Preventive Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Asthma Preventive Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Asthma Preventive Sales Value (2021-2032) & (US$ Million) Figure 36. South America Asthma Preventive Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Asthma Preventive Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Asthma Preventive Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Asthma Preventive Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Asthma Preventive Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Asthma Preventive Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Asthma Preventive Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Asthma Preventive Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Sodium Cromolyn
  • Prednisolone
Applications
  • Children
  • Adult
Companies covered
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GSK
  • Amgen
  • Astrazeneca
  • Sumitomo Dainippon Pharma
  • Chiesi
  • Boehringer Ingelheim
  • Biotest AG
  • Abbot

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Asthma Preventive Sales Value (2021-2032)
  4. 1.2.2 Global Asthma Preventive Sales Volume (2021-2032)
  5. 1.2.3 Global Asthma Preventive Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Asthma Preventive Market Dynamics
  1. 2.1 Asthma Preventive Industry Trends
  2. 2.2 Asthma Preventive Industry Drivers
  3. 2.3 Asthma Preventive Industry Opportunities and Challenges
  4. 2.4 Asthma Preventive Industry Restraints
3 Asthma Preventive Market by Company
  1. 3.1 Global Asthma Preventive Company Revenue Ranking in 2025
  2. 3.2 Global Asthma Preventive Revenue by Company (2021-2026)
  3. 3.3 Global Asthma Preventive Sales Volume by Company (2021-2026)
  4. 3.4 Global Asthma Preventive Average Price by Company (2021-2026)
  5. 3.5 Global Asthma Preventive Company Ranking (2024-2026)
  6. 3.6 Global Asthma Preventive Company Manufacturing Base and Headquarters
  7. 3.7 Global Asthma Preventive Company Product Type and Application
  8. 3.8 Global Asthma Preventive Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Asthma Preventive Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Asthma Preventive Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Asthma Preventive Market by Type
  1. 4.1 Asthma Preventive Type Introduction
  2. 4.1.1 Sodium Cromolyn
  3. 4.1.2 Prednisolone
  4. 4.2 Global Asthma Preventive Sales Volume by Type
  5. 4.2.1 Global Asthma Preventive Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Asthma Preventive Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Asthma Preventive Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Asthma Preventive Sales Value by Type
  9. 4.3.1 Global Asthma Preventive Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Asthma Preventive Sales Value by Type (2021-2032)
  11. 4.3.3 Global Asthma Preventive Sales Value Share by Type (2021-2032)
5 Asthma Preventive Market by Application
  1. 5.1 Asthma Preventive Application Introduction
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Asthma Preventive Sales Volume by Application
  5. 5.2.1 Global Asthma Preventive Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Asthma Preventive Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Asthma Preventive Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Asthma Preventive Sales Value by Application
  9. 5.3.1 Global Asthma Preventive Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Asthma Preventive Sales Value by Application (2021-2032)
  11. 5.3.3 Global Asthma Preventive Sales Value Share by Application (2021-2032)
6 Asthma Preventive Regional Sales and Value Analysis
  1. 6.1 Global Asthma Preventive Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Preventive Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Preventive Sales by Region: 2021-2026
  4. 6.2.2 Global Asthma Preventive Sales by Region (2027-2032)
  5. 6.3 Global Asthma Preventive Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Asthma Preventive Sales Value by Region (2021-2032)
  7. 6.4.1 Global Asthma Preventive Sales Value by Region: 2021-2026
  8. 6.4.2 Global Asthma Preventive Sales Value by Region (2027-2032)
  9. 6.5 Global Asthma Preventive Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Asthma Preventive Sales Value (2021-2032)
  12. 6.6.2 North America Asthma Preventive Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Asthma Preventive Sales Value (2021-2032)
  15. 6.7.2 Europe Asthma Preventive Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Asthma Preventive Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Asthma Preventive Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Asthma Preventive Sales Value (2021-2032)
  21. 6.9.2 South America Asthma Preventive Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Asthma Preventive Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Asthma Preventive Sales Value Share by Country, 2025 VS 2032
7 Asthma Preventive Country-level Sales and Value Analysis
  1. 7.1 Global Asthma Preventive Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Asthma Preventive Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Asthma Preventive Sales by Country (2021-2032)
  4. 7.3.1 Global Asthma Preventive Sales by Country (2021-2026)
  5. 7.3.2 Global Asthma Preventive Sales by Country (2027-2032)
  6. 7.4 Global Asthma Preventive Sales Value by Country (2021-2032)
  7. 7.4.1 Global Asthma Preventive Sales Value by Country (2021-2026)
  8. 7.4.2 Global Asthma Preventive Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Asthma Preventive Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Asthma Preventive Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Asthma Preventive Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Asthma Preventive Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Asthma Preventive Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Asthma Preventive Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Asthma Preventive Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Asthma Preventive Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Asthma Preventive Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Asthma Preventive Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Asthma Preventive Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Asthma Preventive Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Asthma Preventive Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Asthma Preventive Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Asthma Preventive Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Asthma Preventive Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Asthma Preventive Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Asthma Preventive Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Asthma Preventive Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Asthma Preventive Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Asthma Preventive Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Asthma Preventive Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Asthma Preventive Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Asthma Preventive Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Asthma Preventive Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Asthma Preventive Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Asthma Preventive Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Asthma Preventive Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Asthma Preventive Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Asthma Preventive Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Asthma Preventive Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Asthma Preventive Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merck Asthma Preventive Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Roche Asthma Preventive Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Asthma Preventive Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 GSK
  26. 8.5.1 GSK Company Information
  27. 8.5.2 GSK Business Overview
  28. 8.5.3 GSK Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 GSK Asthma Preventive Product Portfolio
  30. 8.5.5 GSK Recent Developments
  31. 8.6 Amgen
  32. 8.6.1 Amgen Company Information
  33. 8.6.2 Amgen Business Overview
  34. 8.6.3 Amgen Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Amgen Asthma Preventive Product Portfolio
  36. 8.6.5 Amgen Recent Developments
  37. 8.7 Astrazeneca
  38. 8.7.1 Astrazeneca Company Information
  39. 8.7.2 Astrazeneca Business Overview
  40. 8.7.3 Astrazeneca Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Astrazeneca Asthma Preventive Product Portfolio
  42. 8.7.5 Astrazeneca Recent Developments
  43. 8.8 Sumitomo Dainippon Pharma
  44. 8.8.1 Sumitomo Dainippon Pharma Company Information
  45. 8.8.2 Sumitomo Dainippon Pharma Business Overview
  46. 8.8.3 Sumitomo Dainippon Pharma Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio
  48. 8.8.5 Sumitomo Dainippon Pharma Recent Developments
  49. 8.9 Chiesi
  50. 8.9.1 Chiesi Company Information
  51. 8.9.2 Chiesi Business Overview
  52. 8.9.3 Chiesi Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chiesi Asthma Preventive Product Portfolio
  54. 8.9.5 Chiesi Recent Developments
  55. 8.10 Boehringer Ingelheim
  56. 8.10.1 Boehringer Ingelheim Company Information
  57. 8.10.2 Boehringer Ingelheim Business Overview
  58. 8.10.3 Boehringer Ingelheim Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Boehringer Ingelheim Asthma Preventive Product Portfolio
  60. 8.10.5 Boehringer Ingelheim Recent Developments
  61. 8.11 Biotest AG
  62. 8.11.1 Biotest AG Company Information
  63. 8.11.2 Biotest AG Business Overview
  64. 8.11.3 Biotest AG Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Biotest AG Asthma Preventive Product Portfolio
  66. 8.11.5 Biotest AG Recent Developments
  67. 8.12 Abbot
  68. 8.12.1 Abbot Company Information
  69. 8.12.2 Abbot Business Overview
  70. 8.12.3 Abbot Asthma Preventive Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Abbot Asthma Preventive Product Portfolio
  72. 8.12.5 Abbot Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Preventive Value Chain Analysis
  2. 9.1.1 Asthma Preventive Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Preventive Sales Mode & Process
  6. 9.2 Asthma Preventive Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Preventive Distributors
  9. 9.2.3 Asthma Preventive Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst